PARADIMGS · CFTY720D2311
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A two-year, double-blind, randomized, multicenter, active controlled study to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly in pediatric patients with multiple sclerosis with five-year fingolimod Extension Phase. EudraCT: 2011-005677-23
Sponsor: NOVARTIS
Phase: III
Area: Neuroimmunology